I’m delighted to announce @chaidiscovery's collaboration with @pfizer. Their scientists will deploy our AI platform to accelerate drug discovery, including early access to our latest frontier model Chai-3.
You can learn more about this partnership and our momentum in @amyfeldman's feature in @Forbes out today
https://t.co/VBoynDgPCz
"We have this long term vision of turning biology from something which is trial and error and experimental and make it something that looks more like an engineering discipline in the next century."
New Episode with @jackdent !
0:00 Intro
02:28 Inside @stripe w/ @patrickc, at <100 People
08:45 @sama role in @chaidiscovery origin
16:20 Chai-2 Antibody Breakthrough
19:24 Approaching biology as an engineering problem
24:45 Using AI models to treat people on an individual scale
26:52 Robotics in labs
27:22 Pharma industry today
29:49 The clinical trial bottleneck
32:53 Personalized biology models & cancer vaccines
36:24 Longevity, peptides, and trillion-dollar drugs
39:02 Does it matter that the government cut exploratory science grants?
41:00 What next-gen Chai models will do
42:08 Can frontier AI labs build this themselves?
43:26 Biology is hard
Memo: What If We're Right?
We recently wrote a private letter to partners & friends of a common failure mode: the inability to consistently reason through the daisy chain of downstream consequence when non-consensus, low-probability, events actually occur
pages: 1-3
Grateful to share the stage with @robzirk and @BenjamineYLiu at PhRMA Forum today. We are at a critical inflection point for the industry. AI deployment is taking off, and 2026 will be the year get a glimpse of how it will transform the future of medicine.
Today at PhRMA Forum, I had the privilege of discussing the power of AI in health care with @jackdent and @BenjamineYLiu.
AI has the potential to transform drug discovery and development. Even just looking at the start of 2025 to today, the results of this new technology are unimaginable. AI is helping scientists design better medicines, eliminate bad ideas earlier and run faster clinical trials.
This is why it’s essential for America to continue leading in technology and biopharma innovation. We must do all we can to accelerate the next generation of treatments and cures.
applications for Embed now open, due 2/9
Embed is a Schelling Point for the best early stage founders. cash, compute, community, and a catalyst
past participants were dropouts, leading researchers and repeat founders. alumni have raised more than a billion dollars
links below
2026 has kicked off with a stream of AI platform deals across pharma, signaling a cultural shift away from single-asset bets and toward AI infrastructure for broad discovery.
@NOETIK_ai, @chaidiscovery, @boltz_bio
Read at @GENbio:
https://t.co/iK6dJF6bz3
I’m proud to announce Chai Discovery’s partnership with Eli Lilly to accelerate the discovery of next-generation therapeutics. Through this collaboration, we'll deploy our frontier models, train custom models on Lilly's proprietary data, and create an entirely new toolchain for discovering life-changing medicines.
We’re thrilled to announce our collaboration with @EliLillyandCo.
We’ll be deploying Chai’s AI models to power biologics discovery across a broad set of drug programs at Lilly.
This is a major step forward in pharma’s adoption of AI-native R&D.
Congrats to @joshim5@jackdent@chaidiscovery on their first major deal announcement with Eli Lilly! Always amazing to see their pace to adoption. 2026 looks like the tipping point in pharma adoption of AI tools up and down the stack! https://t.co/LrzhR36pmv